Opsin Biotherapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$328K
- Investors
-
5
Opsin Biotherapeutics General Information
Description
Developer of an optogenetic neuromodulation platform designed to treat chronic pain through precise control of neural activity. The company offers gene therapy-based pain management using light-sensitive proteins and targeted neural modulation, enabling clinicians to provide effective, non-opioid care for patients with chronic pain.
Contact Information
Website
www.opsinbio.comCorporate Office
- 1312 Brown Trail
- Bedford, TX 76022
- United States
Corporate Office
- 1312 Brown Trail
- Bedford, TX 76022
- United States
Opsin Biotherapeutics Timeline
Opsin Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 27-Jul-2023 | $328K | Completed | Pre-Clinical Trials | ||
| 3. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 2. Joint Venture | 06-Mar-2019 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Opsin Biotherapeutics Comparisons
Industry
Financing
Details
Opsin Biotherapeutics Competitors (2)
One of Opsin Biotherapeutics’s 2 competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Abbott | Corporation | Abbot Park, IL |
Opsin Biotherapeutics Patents
Opsin Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025209159-A1 | Opto genetic delivery device and methods of using the same | Pending | 18-Jan-2024 | ||
| WO-2025155944-A1 | Opto genetic delivery device and methods of using the same | Pending | 18-Jan-2024 | ||
| AU-2024225157-A1 | Optogenetic modulation of central nervous system for treating pain | Pending | 20-Feb-2023 | ||
| EP-4669426-A2 | Optogenetic modulation of central nervous system for treating pain | Pending | 20-Feb-2023 | ||
| US-20260263830-A1 | Optogenetic modulation of central nervous system for treating pain | Pending | 20-Feb-2023 | A61N5/062 |
Opsin Biotherapeutics Signals
Opsin Biotherapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Neurological Disorders and Stroke | Government | |||
| Texas A&M New Ventures Competition | University | |||
| DesignPlex Biomedical | Corporation | Majority | ||
| Nanoscope Technologies | Corporation | Majority | ||
| HSC Next | Accelerator/Incubator |
Opsin Biotherapeutics FAQs
-
When was Opsin Biotherapeutics founded?
Opsin Biotherapeutics was founded in 2019.
-
Where is Opsin Biotherapeutics headquartered?
Opsin Biotherapeutics is headquartered in Bedford, TX.
-
What is the size of Opsin Biotherapeutics?
Opsin Biotherapeutics has 3 total employees.
-
What industry is Opsin Biotherapeutics in?
Opsin Biotherapeutics’s primary industry is Biotechnology.
-
Is Opsin Biotherapeutics a private or public company?
Opsin Biotherapeutics is a Private company.
-
What is Opsin Biotherapeutics’s current revenue?
The current revenue for Opsin Biotherapeutics is .
-
Who are Opsin Biotherapeutics’s investors?
National Institutes of Neurological Disorders and Stroke, Texas A&M New Ventures Competition, DesignPlex Biomedical, Nanoscope Technologies, and HSC Next have invested in Opsin Biotherapeutics.
-
Who are Opsin Biotherapeutics’s competitors?
Boston Scientific and Abbott are competitors of Opsin Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process